Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis.
Johnen A, Elpers C, Riepl E, Landmeyer NC, Krämer J, Polzer P, Lohmann H, Omran H, Wiendl H, Göbel K, Meuth SG
Research article (journal) | Peer reviewedAbstract
9 patients (47%) were impaired in at least one test at baseline (z-score
Details about the publication
Journal: European Journal of Paediatric Neurology
Volume: 23
Issue: 6
Page range: 783-791
Status: Published
Release year: 2019 (30/11/2019)
Language in which the publication is written: English
Keywords: Adjuvants, Immunologic; Adolescent; Child; Cognitive Dysfunction; Cohort Studies; Executive Function; Female; Humans; Interferon beta-1a; Male; Multiple Sclerosis; Neuropsychological Tests; Treatment Outcome
Authors from the University of Münster
| Krämer, Julia | Department for Neurology |
| Landmeyer, Nils Christian | Department for Neurology |
| Wiendl, Heinz Siegfried | Department for Neurology |